1. 1Department of Medicine, Medical Clinic III, Ludwig-Maximilian-University Hospital, Munich, Germany
2. 2The University of Texas MD Anderson Cancer Center, Houston, TX
3. 3BostonGene, Waltham, MA
4. 4Peter MacCallum Cancer Centre, Royal Melbourne Hospital and the Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia
5. 5Hospital 12 De Octubre, Complutense University, Centro Nacional de Investigaciones Oncológicas, Madrid, Spain
6. 6Oslo University Hospital, Oslo, Norway
7. 7Royal Brisbane Hospital, Herston, QLD, Australia
8. 8Division of Hematology/Oncology, Michigan Medicine University of Michigan, Ann Arbor, MI
9. 9City of Hope Comprehensive Cancer Center, Duarte, CA
10. 10Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
11. 11Clinical Hematology, Hospices Civils de Lyon and Université Claude Bernard Lyon 1, Lyon, France
12. 12Department of Hematology, Oncology, and Cardiovascular Medicine, Kyushu University Hospital, Fukuoka, Japan
13. 13Department of Hematology, Tohoku University Hospital, Sendai, Japan
14. 14Department of Hematology, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands, on behalf of Stichting Hemato-Oncologie voor Volwassenen Nederland/Lunenburg Lymphoma Phase I/II Consortium
15. 15Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA
16. 16David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL
17. 17Institute of Haematology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia
18. 18Department of Hematology, University Hospital Virgen del Rocío, Instituto de Biomedicina de Sevilla Consejo Superior de Investigaciones Cientificas, Universidad de Sevilla, Seville, Spain
19. 19Oregon Health and Science University, Portland, OR
20. 20Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
21. 21Department I of Internal Medicine, Medical Faculty and University Hospital Cologne, University of Cologne, Cologne, Germany
22. 22Department of Hematology and Stem Cell Transplantation, West German Cancer Center and German Cancer Consortium, University Hospital Essen, University of Duisburg-Essen, Essen, Germany
23. 23Unit of Lymphoid Malignancies, Department of Onco-Haematology, IRCCS San Raffaele Scientific Institute, Milan, Italy
24. 24Department of Hematology, Hokkaido University Hospital, Sapporo, Japan
25. 25Comprehensive Cancer Centre, King’s College London, London, United Kingdom
26. 26Department of Haematology, King’s College Hospital, London, United Kingdom
27. 27Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Cancer l Center, Westwood, KS
28. 28Internal Medicine I, Ordensklinikum Linz Barmherzige Schwestern-Elisabethinen, Linz, Austria
29. 29Universitair Ziekenhuis Gent, Ghent, Belgium
30. 30Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany
31. 31IRCCS Azienda Ospedaliero-Universitaria di Bologna Istituto di Ematologia “Seràgnoli,” Bologna, Italy
32. 32Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy
33. 33Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom
34. 34Novartis Pharma AG, Basel, Switzerland
35. 35Novartis Institutes for BioMedical Research, East Hanover, NJ
36. 36Novartis Pharmaceuticals Corporation, East Hanover, NJ
37. 37Novartis Pharmaceuticals Corporation, Dublin, Ireland
38. 38Service d'hémato-oncologie, Hôpital Saint-Louis, Paris, France
39. 39Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA